At BOC Sciences, we provide a comprehensive portfolio of glycan reagents designed to advance research in glycoscience, biopharmaceutical development, diagnostics, and vaccine innovation. Our products cover a wide spectrum of N-glycans, O-glycans, lipopolysaccharides (LPS), and labeled glycans, offering researchers high-quality, reliable tools to study glycosylation pathways and their biological functions. Whether you are investigating protein glycosylation, developing glycan-specific diagnostics, or engineering glyco-optimized therapeutics, our reagents are produced with the highest standards of purity and reproducibility. By combining ready-to-use glycans with the option for custom synthesis and labeling, we ensure that you have the flexibility to accelerate your discoveries from basic glycoscience research to clinical applications.
Molecular Formula: C62H114N2O22
Molecular Weight: 1239.59
Classification: Glycosphingolipid
Molecular Formula: C78H140N6O27S
Molecular Weight: 1626.05
Classification: Biotin Modification
Molecular Formula: C60H111NO22
Molecular Weight: 1198.53
Classification: Glycosphingolipid
Molecular Formula: C76H137N5O27S
Molecular Weight: 1585
Classification: Biotin Modification
Molecular Formula: C32H35NO14
Molecular Weight: 657.63
Classification: O-Glycoamino acid
Molecular Formula: C33H37NO14
Molecular Weight: 671.65
Classification: O-Glycoamino acid
Molecular Formula: C79H141N3O35
Molecular Weight: 1692.98
Classification: Glycosphingolipid
Molecular Formula: C95H167N7O40S
Molecular Weight: 2079.45
Classification: Biotin Modification
Molecular Formula: C61H107N3O34
Molecular Weight: 1426.51
Classification: Glycosphingolipid
Molecular Formula: C70H127N5O23S
Molecular Weight: 1438.86
Classification: Biotin Modification
Molecular Formula: C78H140N6O28S
Molecular Weight: 1642.05
Classification: Biotin Modification
Molecular Formula: C84H150N6O33S
Molecular Weight: 1804.19
Classification: Biotin Modification
Molecular Formula: C84H148N4O39
Molecular Weight: 1838.1
Classification: Glycosphingolipid
Molecular Formula: C100H174N8O44S
Molecular Weight: 2224.56
Classification: Biotin Modification
Molecular Formula: C78H138N4O34
Molecular Weight: 1675.96
Classification: Glycosphingolipid
Molecular Formula: C94H164N8O39S
Molecular Weight: 2062.42
Classification: Biotin Modification
Molecular Formula: C70H125N3O29
Molecular Weight: 1472.76
Classification: Glycosphingolipid
Molecular Formula: C86H151N7O34S
Molecular Weight: 1859.23
Classification: Biotin Modification
Molecular Formula: C90H160N6O37S
Molecular Weight: 1950.34
Classification: Biotin Modification
Molecular Formula: C55H97N3O30
Molecular Weight: 1280.37
Classification: Glycosphingolipid
Molecular Formula: C89H157N7O36S
Molecular Weight: 1933.31
Classification: Biotin Modification
Molecular Formula: C67H121N3O26
Molecular Weight: 1384.7
Classification: Glycosphingolipid
Molecular Formula: C83H147N7O31S
Molecular Weight: 1771.17
Classification: Biotin Modification
Molecular Formula: C49H87N3O25
Molecular Weight: 1118.23
Classification: Glycosphingolipid
Molecular Formula: C59H108N2O21
Molecular Weight: 1181.51
Classification: Glycosphingolipid
Molecular Formula: C70H127N5O22S
Molecular Weight: 1422.86
Classification: Biotin Modification
Molecular Formula: C41H74N2O20
Molecular Weight: 915.04
Classification: Glycosphingolipid
Molecular Formula: C97H168N8O42S
Molecular Weight: 2150.49
Classification: Biotin Modification
Molecular Formula: C54H101NO17
Molecular Weight: 1036.39
Classification: Glycosphingolipid
Molecular Formula: C70H127N5O22S
Molecular Weight: 1422.86
Classification: Biotin Modification
Molecular Formula: C54H101NO18
Molecular Weight: 1052.39
Classification: Glycosphingolipid
Molecular Formula: C70H127N5O23S
Molecular Weight: 1438.86
Classification: Biotin Modification
Molecular Formula: C62H114N2O23
Molecular Weight: 1255.59
Classification: Glycosphingolipid
Molecular Formula: C78H140N6O28S
Molecular Weight: 1642.05
Classification: Biotin Modification
Molecular Formula: C84H150N6O33S
Molecular Weight: 1804.19
Classification: Biotin Modification
Molecular Formula: C90H160N6O37S
Molecular Weight: 1950.34
Classification: Biotin Modification
Molecular Formula: C64H117N5O18S
Molecular Weight: 1276.72
Classification: Biotin Modification
Molecular Formula: C32H61NO12
Molecular Weight: 651.84
Classification: Glycosphingolipid
Molecular Formula: C56H104N2O18
Molecular Weight: 1093.44
Classification: Glycosphingolipid
Molecular Formula: C72H130N6O23S
Molecular Weight: 1479.91
Classification: Biotin Modification
Molecular Formula: C62H114N2O23
Molecular Weight: 1255.59
Classification: Glycosphingolipid
Molecular Formula: C78H140N6O28S
Molecular Weight: 1642.05
Classification: Biotin Modification
Molecular Formula: C84H150N6O32S
Molecular Weight: 1788.19
Classification: Biotin Modification
Molecular Formula: C84H150N6O32S
Molecular Weight: 1788.19
Classification: Biotin Modification
Molecular Formula: C62H114N2O23
Molecular Weight: 1255.59
Classification: Glycosphingolipid
Molecular Formula: C78H140N6O28S
Molecular Weight: 1642.05
Classification: Biotin Modification
Molecular Formula: C95H167N7O41S
Molecular Weight: 2095.45
Classification: Biotin Modification
Molecular Formula: C73H131N3O31
Molecular Weight: 1546.84
Classification: Glycosphingolipid
Molecular Formula: C79H141N3O36
Molecular Weight: 1708.98
Classification: Glycosphingolipid
Molecular Formula: C95H167N7O41S
Molecular Weight: 2095.45
Classification: Biotin Modification
CAS: 1125602-44-9
Molecular Formula: C84H138N6O62
Molecular Weight: 2224.01
Classification: N-Glycan
CAS: 1240252-34-9
Molecular Formula: C57H71N3O28
Molecular Weight: 1246.19
Classification: O-Glycoamino acid
CAS: 125650-87-5
Molecular Formula: C50H95NO13
Molecular Weight: 918.3
Classification: Glycosphingolipid
CAS: 125760-33-0
Molecular Formula: C45H54N2O21
Molecular Weight: 958.92
Classification: O-Glycoamino acid
CAS: 1427205-92-2
Molecular Formula: C56H67NO30
Molecular Weight: 945.88
Classification: O-Glycoamino acid
CAS: 1427205-93-3
Molecular Formula: C56H67NO30
Molecular Weight: 1234.13
Classification: O-Glycoamino acid
CAS: 173935-46-1
Molecular Formula: C30H33NO12
Molecular Weight: 599.59
Classification: O-Glycoamino acid
CAS: 174783-91-6
Molecular Formula: C62H77N3O32
Molecular Weight: 1376.29
Classification: O-Glycoamino acid
CAS: 174783-92-7
Molecular Formula: C63H79N3O32
Molecular Weight: 1390.31
Classification: O-Glycoamino acid
CAS: 189561-77-1
Molecular Formula: C51H63N3O24
Molecular Weight: 1102.06
Classification: O-Glycoamino acid
CAS: 361443-81-4
Molecular Formula: C112H189N15O70
Molecular Weight: 2865.78
Classification: N-Glycan
CAS: 482576-73-8
Molecular Formula: C45H53NO22
Molecular Weight: 959.9
Classification: O-Glycoamino acid
CAS: 482576-74-9
Molecular Formula: C57H69NO30
Molecular Weight: 1248.16
Classification: O-Glycoamino acid
CAS: 67299-24-5
Molecular Formula: C66H110N6O48
Molecular Weight: 1755.6
Classification: N-Glycan
CAS: 68141-38-8
Molecular Formula: C88H144N8O64
Molecular Weight: 2338.11
Classification: N-Glycan
CAS: 914456-67-0
Molecular Formula: C50H61N3O24
Molecular Weight: 1088.04
Classification: O-Glycoamino acid
We provide a complete range of glycan reagents - N-glycans, O-glycans, lipopolysaccharides, and labeled glycans - to support cutting-edge research in glycoscience, biopharma, and vaccine development.
Our N-glycan reagents provide high-purity, structurally defined glycans to support advanced studies of protein glycosylation and its role in health and disease. Covering high-mannose, complex, and hybrid N-glycans, these reagents are ideal for applications in therapeutic antibody development, glycan structural analysis, biomarker discovery, and vaccine research. Engineered for consistency and reproducibility, our N-glycan portfolio enables scientists to explore glycan-protein interactions, evaluate immune recognition, and optimize biopharmaceutical glycosylation patterns.
Related Services
Our O-glycan reagents include a broad selection of core O-glycan structures and extended variants, tailored for studies in mucin biology, cancer glycomics, and host-pathogen interactions. These reagents provide precise tools to dissect O-glycosylation pathways, identify disease-specific glycan markers, and enhance the design of glycan-based diagnostics and therapeutics. With rigorous quality control and application versatility, our O-glycans are trusted by researchers investigating cell signaling, immune modulation, and tumor progression.
Related Services
We supply highly purified lipopolysaccharides (LPS) sourced from well-characterized bacterial strains such as E. coli and Salmonella. Available in both native and detoxified forms, these LPS reagents are essential for research into innate immunity, inflammatory pathways, and vaccine adjuvant development. By delivering reproducible activity and minimized endotoxin variability, our LPS products empower scientists to accurately model host-pathogen interactions, assess immunogenicity, and drive innovation in infectious disease research.
Related Services
Our labeled glycans are designed to facilitate glycomics research, quantitative analysis, and imaging applications. Offered with fluorescent tags and isotope labeling, these reagents allow sensitive detection, profiling, and tracking of glycans across diverse biological systems. With compatibility for HPLC, LC-MS, flow cytometry, and live-cell imaging, our labeled glycans enable breakthroughs in glycan profiling, drug conjugation, and cellular visualization. Tailored options are available to match specific research workflows, ensuring both flexibility and accuracy.
Related Services
Advanced analytical techniques for accurate glycan profiling.
Reliable methods ensuring precise characterization and consistent results.
Our high-purity glycan products are designed to support cutting-edge research and product development across multiple fields in life sciences and biotechnology. From basic glycobiology studies to therapeutic innovation, our catalog provides reliable tools to accelerate discovery.
Standard and custom glycan conjugates play a vital role in glycan-based vaccines, enabling the design of safer and more effective immunizations against infectious diseases.
N-glycans, O-glycans, and engineered glycans support antibody optimization and antibody-drug conjugate (ADC) development, improving efficacy, stability, and therapeutic performance.
Biotinylated and fluorescently labeled glycans facilitate high-sensitivity assays, imaging, and glycan array platforms for cancer, infectious disease, and immune disorder diagnostics.
Comprehensive glycan libraries and arrays empower researchers to study glycan-protein interactions, cell signaling, and structural biology, providing insights into fundamental mechanisms of health and disease.
Our catalog supports drug screening and SAR (structure-activity relationship) studies by providing reliable glycan building blocks for glycan-targeted therapeutics and next-generation drug development.